| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 762 | 1.370 | 1.522 | 4.457 | 3.038 | 5.511 | 7.358 |
| Total Income - EUR | - | - | - | 762 | 1.370 | 1.522 | 4.457 | 3.038 | 5.511 | 7.358 |
| Total Expenses - EUR | - | - | - | 364 | 676 | 318 | 438 | 598 | 803 | 3.728 |
| Gross Profit/Loss - EUR | - | - | - | 398 | 694 | 1.204 | 4.019 | 2.440 | 4.708 | 3.631 |
| Net Profit/Loss - EUR | - | - | - | 375 | 653 | 1.159 | 3.885 | 2.349 | 4.068 | 2.996 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Enache-Urologic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 456 |
| Current Assets | - | - | - | 868 | 1.067 | 2.214 | 3.935 | 2.449 | 6.656 | 5.229 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 138 | 347 | 381 | 318 | 685 | 279 | 277 |
| Cash | - | - | - | 730 | 720 | 1.834 | 3.618 | 1.763 | 6.377 | 4.952 |
| Shareholders Funds | - | - | - | 418 | 1.063 | 2.202 | 3.926 | 2.390 | 6.450 | 5.365 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 449 | 4 | 12 | 10 | 59 | 206 | 321 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Enache-Urologic S.r.l.